Prihlásiť sa Zaregistrujte sa zadarmo

Beta spoločnosti NeuroVive Pharmaceutical AB

Aká je hodnota metriky Beta spoločnosti NeuroVive Pharmaceutical AB?

Hodnota metriky Beta spoločnosti NeuroVive Pharmaceutical AB je 0.93

Aká je definícia metriky Beta?



BETA koeficient vyjadruje či je akcia volatilnejšia ako celkový trh. Beta nižšie ako 1 značí, že akcia je menej volatilná ako trh a beta vyššie ako 1 značí, že akcia je volatilnejšia. Volatilita sa miera pomocou kolísavosti ceny akcie.

Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.

Beta spoločností v sektore Miscellaneous sektor na LSE v porovnaní so spoločnosťou NeuroVive Pharmaceutical AB

Čomu sa venuje spoločnosť NeuroVive Pharmaceutical AB?

Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.

Firmy s metrikou beta podobnou spoločnosti NeuroVive Pharmaceutical AB